
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.390 | 0.390 | 0.000 |
Shares | 98.920 | 98.920 | 0.000 |
Other | 0.680 | 0.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.945 | 14.542 |
Price to Book | 2.168 | 2.028 |
Price to Sales | 1.765 | 1.465 |
Price to Cash Flow | 9.993 | 9.121 |
Dividend Yield | 3.405 | 3.396 |
5 Years Earnings Growth | 8.371 | 9.279 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 21.900 | 20.124 |
Industrials | 17.980 | 16.775 |
Healthcare | 13.810 | 13.978 |
Consumer Defensive | 10.520 | 10.933 |
Consumer Cyclical | 7.750 | 9.494 |
Technology | 7.400 | 9.035 |
Basic Materials | 6.130 | 6.308 |
Utilities | 4.670 | 4.637 |
Communication Services | 4.580 | 5.525 |
Energy | 4.350 | 4.430 |
Real Estate | 0.900 | 1.754 |
Number of long holdings: 229
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.68 | 260.550 | -1.86% | |
ASML Holding | NL0010273215 | 2.29 | 642.60 | -2.16% | |
Nestle | CH0038863350 | 2.28 | 88.52 | +0.42% | |
Novartis | CH0012005267 | 2.12 | 92.76 | -0.26% | |
Roche Holding Participation | CH0012032048 | 2.05 | 259.90 | +0.27% | |
Novo Nordisk B | DK0062498333 | 2.01 | 443.0 | -0.76% | |
AstraZeneca | GB0009895292 | 1.81 | 10,436.0 | +0.60% | |
Shell | GB00BP6MXD84 | 1.61 | 29.00 | -0.55% | |
Louis Vuitton | FR0000121014 | 1.53 | 479.00 | -1.26% | |
HSBC | GB0005405286 | 1.49 | 868.80 | -1.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0058496679 | 2.47B | -14.48 | 5.57 | 8.40 | ||
LU0553726919 | 539.21M | -0.92 | -1.27 | -2.52 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review